Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kittichai Promrat

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Journal of Clinical Medicine|October 16, 2024
Impact of Non-Alcoholic Fatty Liver Disease on Sepsis Inpatient Outcomes: A Nationwide Sample Analysis (2000-2019)Xiuhong Lyu, Bolun Liu, Yiting Li, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 15, 2023
Prevalence and Characteristics of Nonalcoholic Fatty Liver Disease and Fibrosis in People Living With HIV Monoinfection: A Systematic Review and Meta-analysisMarkos Kalligeros, Athanasios Vassilopoulos, Fadi Shehadeh, et al.
AJR. American Journal of Roentgenology|August 23, 2014
A pilot study estimating liver fibrosis with ultrasound shear-wave elastography: does the cause of liver disease or location of measurement affect performance?Michael D Beland, Sanford F Brown, Jason T Machan, et al.
Annals of Gastroenterology|November 29, 2023
Prevalence and risk factors of nonalcoholic fatty liver disease, high-risk nonalcoholic steatohepatitis, and fibrosis among lean United States adults: NHANES 2017-2020Markos Kalligeros, Stephanos Vassilopoulos, Athanasios Vassilopoulos, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 4, 2006
Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvementGlen Lutchman, Kittichai Promrat, David E Kleiner, et al.
Digestive Diseases and Sciences|January 6, 2024
Prevalence of Steatotic Liver Disease Among US Adults with Rheumatoid ArthritisAthanasios Vassilopoulos, Markos Kalligeros, Stephanos Vassilopoulos, et al.
Hepatology (Baltimore, Md.)|October 15, 2009
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitisKittichai Promrat, David E Kleiner, Heather M Niemeier, et al.
Journal of Viral Hepatitis|June 13, 2023
Impact of prior HBV, HAV, and HEV infection on non-alcoholic fatty liver diseaseStephanos Vassilopoulos, Markos Kalligeros, Athanasios Vassilopoulos, et al.
Hepatology (Baltimore, Md.)|October 24, 2002
Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis CAlejandro Soza, James E Everhart, Marc G Ghany, et al.
Gastroenterology|January 4, 2003
Progression of fibrosis in chronic hepatitis CMarc G Ghany, David E Kleiner, Harvey Alter, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Journal of Clinical Medicine|October 16, 2024
Impact of Non-Alcoholic Fatty Liver Disease on Sepsis Inpatient Outcomes: A Nationwide Sample Analysis (2000-2019)Xiuhong Lyu, Bolun Liu, Yiting Li, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 15, 2023
Prevalence and Characteristics of Nonalcoholic Fatty Liver Disease and Fibrosis in People Living With HIV Monoinfection: A Systematic Review and Meta-analysisMarkos Kalligeros, Athanasios Vassilopoulos, Fadi Shehadeh, et al.
AJR. American Journal of Roentgenology|August 23, 2014
A pilot study estimating liver fibrosis with ultrasound shear-wave elastography: does the cause of liver disease or location of measurement affect performance?Michael D Beland, Sanford F Brown, Jason T Machan, et al.
Annals of Gastroenterology|November 29, 2023
Prevalence and risk factors of nonalcoholic fatty liver disease, high-risk nonalcoholic steatohepatitis, and fibrosis among lean United States adults: NHANES 2017-2020Markos Kalligeros, Stephanos Vassilopoulos, Athanasios Vassilopoulos, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 4, 2006
Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvementGlen Lutchman, Kittichai Promrat, David E Kleiner, et al.
Digestive Diseases and Sciences|January 6, 2024
Prevalence of Steatotic Liver Disease Among US Adults with Rheumatoid ArthritisAthanasios Vassilopoulos, Markos Kalligeros, Stephanos Vassilopoulos, et al.
Hepatology (Baltimore, Md.)|October 15, 2009
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitisKittichai Promrat, David E Kleiner, Heather M Niemeier, et al.
Journal of Viral Hepatitis|June 13, 2023
Impact of prior HBV, HAV, and HEV infection on non-alcoholic fatty liver diseaseStephanos Vassilopoulos, Markos Kalligeros, Athanasios Vassilopoulos, et al.
Hepatology (Baltimore, Md.)|October 24, 2002
Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis CAlejandro Soza, James E Everhart, Marc G Ghany, et al.
Gastroenterology|January 4, 2003
Progression of fibrosis in chronic hepatitis CMarc G Ghany, David E Kleiner, Harvey Alter, et al.
Pageof 4